Increased risk of severe infections in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis

BACKGROUND: Vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) have been widely used in a variety of solid malignancies. Concerns have arisen regarding the risk of severe infections (≥grade 3) with use of these drugs, but the contribution of VEGFR-TKIs to infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Qing, Gu, Li-Yan, Ren, Yao-Yao, Zeng, Li-Li, Gong, Ting, Zhong, Dian-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559247/
https://www.ncbi.nlm.nih.gov/pubmed/26355897
http://dx.doi.org/10.2147/OTT.S87298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559247/
https://www.ncbi.nlm.nih.gov/pubmed/26355897
http://dx.doi.org/10.2147/OTT.S87298

Ejemplares similares